Attached files

file filename
8-K - FORM 8-K - Acadia Healthcare Company, Inc.d148895d8k.htm

Exhibit 99

Acadia Healthcare Company, Inc.

Reconciliation of Net Income Attributable to Acadia Healthcare Company, Inc. to Adjusted EBITDA

(Unaudited)

 

     Three Months Ended December 31, 2015     Year Ended December 31, 2015  
     Form 10-K     Earnings Release     Form 10-K     Earnings Release  
     (in thousands)  

Net income attributable to Acadia Healthcare Company, Inc.

   $ 34,566      $ 41,557      $ 112,554      $ 119,545   

Income from discontinuing operations, net of income taxes

     (28     (28     (111     (111

Net loss attributable to noncontrolling interests

     (614     (614     (1,078     (1,078

Provision for income taxes

     18,594        11,603        53,388        46,397   

Interest expense, net

     28,810        28,810        106,742        106,742   

Depreciation and amortization

     18,630        18,630        63,550        63,550   
  

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA

     99,958        99,958        335,045        335,045   

Adjustments:

        

Equity-based compensation expense (a)

     5,896        5,896        20,472        20,472   

Debt extinguishment costs (b)

     839        839        10,818        10,818   

Loss on foreign currency derivatives (c)

     —          —          1,926        1,926   

Transaction-related expenses (d)

     5,156        5,156        36,571        36,571   
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted EBITDA

   $ 111,849      $ 111,849      $ 404,832      $ 404,832   
  

 

 

   

 

 

   

 

 

   

 

 

 

See footnotes.

Acadia Healthcare Company, Inc.

Reconciliation of Adjusted Income from Continuing Operations Attributable to Acadia Healthcare Company, Inc. to

Net Income Attributable to Acadia Healthcare Company, Inc.

(Unaudited)

 

     Three Months Ended December 31, 2015     Year Ended December 31, 2015  
     Form 10-K     Earnings Release     Form 10-K     Earnings Release  
     (in thousands, except per share amounts)  

Net income attributable to Acadia Healthcare Company, Inc.

   $ 34,566      $ 41,557      $ 112,554      $ 119,545   

Income from discontinuing operations, net of income taxes

     (28     (28     (111     (111

Provision for income taxes

     18,594        11,603        53,388        46,397   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations attributable to Acadia Healthcare Company, Inc. before income taxes

     53,132        53,132        165,831        165,831   

Adjustments to income from continuing operations:

        

Debt extinguishment costs (b)

     839        839        10,818        10,818   

Loss on foreign currency derivatives (c)

     —          —          1,926        1,926   

Transaction-related expenses (d)

     5,156        5,156        36,571        36,571   

Income tax provision reflecting tax effect of adjustments to income from continuing operations (e)

     (16,834     (16,834     (62,392     (62,392
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted income from continuing operations attributable to Acadia Healthcare Company, Inc.

   $ 42,293      $ 42,293      $ 152,754      $ 152,754   

Weighted-average shares outstanding - diluted

     71,145        71,145        68,391        68,391   

Adjusted income from continuing operations attributable to Acadia Healthcare Company, Inc. per diluted share

   $ 0.59      $ 0.59      $ 2.23      $ 2.23   
  

 

 

   

 

 

   

 

 

   

 

 

 

See footnotes.


Acadia Healthcare Company, Inc.

Footnotes

We have included certain financial measures in this report, including EBITDA, Adjusted EBITDA and Adjusted income from continuing operations, which are “non-GAAP financial measures” as defined under the rules and regulations promulgated by the SEC. We define EBITDA as net income adjusted for loss from discontinued operations, net interest expense, income tax provision and depreciation and amortization. We define Adjusted EBITDA as EBITDA adjusted for equity-based compensation expense, debt extinguishment costs, gain on foreign currency derivatives and transaction-related expenses.

EBITDA, Adjusted EBITDA and Adjusted income from continuing operations are supplemental measures of our performance and are not required by, or presented in accordance with, generally accepted accounting principles in the United States (“GAAP”). EBITDA, Adjusted EBITDA and Adjusted income from continuing operations are not measures of our financial performance under GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with GAAP or as an alternative to cash flow from operating activities as measures of our liquidity. Our measurements of EBITDA, Adjusted EBITDA and Adjusted income from continuing operations may not be comparable to similarly titled measures of other companies. We have included information concerning EBITDA, Adjusted EBITDA and Adjusted income from continuing operations in this report because we believe that such information is used by certain investors as measures of a company’s historical performance. We believe these measures are frequently used by securities analysts, investors and other interested parties in the evaluation of issuers of equity securities, many of which present EBITDA, Adjusted EBITDA and Adjusted income from continuing operations when reporting their results. Our presentation of EBITDA, Adjusted EBITDA and Adjusted income from continuing operations should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.

 

(a) Represents the equity-based compensation expense of Acadia.

 

(b) Represents debt extinguishment costs related to the repayment of $97.5 million of the Company’s 12.875% Senior Notes due 2018, including a prepayment premium of $7.5 million and the write-off of $3.3 million of deferred financing costs.

 

(c) Represents the change in fair value of foreign currency derivatives purchased by Acadia related to acquisitions in the U.K. during 2015 and in July 2014.

 

(d) Represents transaction-related expenses incurred by Acadia related to acquisitions.

 

(e) Represents the income tax provision adjusted to reflect the tax effect of the adjustments to income from continuing operations based on tax rates of 28.5% and 27.9% for the three months ended December 31, 2015 and 2014, respectively, and 29.0% and 31.7% for the year ended December 31, 2015 and 2014, respectively.